Takeda Pharmaceutical Co Ltd (TAK): who owns it and who trades it
As of Nov 16, 2026, TAK insiders reported 22 open-market sales worth $15.2M and no purchases in the last 12 months, with 16% of the sale value made under pre-set 10b5-1 plans. The largest seller was Andrew Stewart Plump (President), with $5.3M. 8 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Takeda Pharmaceutical
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns TAK
377 funds and institutions reported TAK shares worth $1.7B at the end of Q2 2026. The largest holder is Capital Research Global Investors with $309M.
10 largest owners, by value
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Capital Research Global Investors | 19.30M | – | $309M | +1% |
| FMR LLC (Fidelity) | 9.60M | – | $154M | +35% |
| Morgan Stanley | 6.99M | – | $112M | +8% |
| Adage Capital Partners Gp, L.l.c. | 6.05M | – | $97M | -6% |
| Goldman Sachs Group Inc | 5.13M | – | $82.2M | -9% |
| Brandes Investment Partners, LP | 4.54M | – | $72.8M | +2% |
| Arrowstreet Capital, Limited Partnership | 3.73M | – | $59.8M | +20% |
| BlackRock, Inc. | 3.69M | – | $59.1M | +16% |
| Renaissance Technologies LLC | 2.57M | – | $41.2M | -14% |
| Qube Research & Technologies Ltd | 2.21M | – | $35.4M | – |
| First Trust Advisors LP | 2.11M | – | $33.9M | +7% |
| D. E. Shaw & Co., Inc. | 2.05M | – | $32.9M | -21% |
| Managed Asset Portfolios, LLC | 1.82M | – | $29.2M | +1% |
| Northern Trust Corp | 1.74M | – | $27.9M | -11% |
| Van Eck Associates Corp | 1.67M | – | $26.8M | -26% |
| Envestnet Asset Management Inc | 1.60M | – | $25.6M | +13% |
| AQR Capital Management LLC | 1.53M | – | $24.5M | +71% |
| Quantinno Capital Management LP | 1.40M | – | $22.5M | +9% |
| Wells Fargo & Company | 1.15M | – | $18.4M | +1% |
| Millennium Management LLC | 1.05M | – | $16.8M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, TAK insiders reported $0 of open-market purchases and $15.2M of sales. 16% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Giles Richard Platford | President | Sale | 55,617 | $20.90 | $1.2M | Form 4 |
| Nov 2, 2026 | Teresa Marie Bitetti | President | Sale | 46,609 | $20.89 | $974K | Form 4 |
| Sep 14, 2026 | Lauren Rusckowski Duprey | Chief Transformation Off | Sale | 34,535 | $18.54 | $640K | Form 4 |
| Sep 2, 2026 | Andrew Stewart Plump | President | Sale plan | 116,191 | $18.49 | $2.1M | Form 4 |
| Aug 19, 2026 | Andrew Stewart Plump | President | Sale plan | 19,651 | $18.49 | $363K | Form 4 |
| Aug 18, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Of | Sale | 12,980 | $18.11 | $235K | Form 4 |
| Aug 11, 2026 | Elaine Mary Shannon | Pres. | Sale | 20,363 | $17.55 | $357K | Form 4 |
| Aug 10, 2026 | Awny Samaan Botros Farajallah | Chief Medical Officer | Sale | 14,006 | $17.10 | $240K | Form 4 |
| Aug 10, 2026 | Ramy Riad Ahmed Ibrahim | President | Sale | 7,277 | $17.10 | $124K | Form 4 |
| Aug 10, 2026 | Rhonda Janice Pacheco | President | Sale | 16,901 | $17.10 | $289K | Form 4 |
| Aug 10, 2026 | Lauren Rusckowski Duprey | Chief Transformation Off | Sale | 47,586 | $17.10 | $814K | Form 4 |
| Aug 10, 2026 | Andrew Stewart Plump | President | Sale | 165,393 | $17.10 | $2.8M | Form 4 |
| Aug 10, 2026 | Agosti Marcello Pignagnoli | Head | Sale | 22,957 | $17.10 | $393K | Form 4 |
| Aug 10, 2026 | Teresa Marie Bitetti | President | Sale | 50,012 | $17.10 | $855K | Form 4 |
| Aug 10, 2026 | Elaine Mary Shannon | Pres. | Sale | 3,978 | $17.10 | $68K | Form 4 |
| Aug 10, 2026 | Gabriele Ricci | Chief Data & Tech. Offic | Sale | 25,088 | $17.10 | $429K | Form 4 |
| Aug 10, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Of | Sale | 6,774 | $17.10 | $116K | Form 4 |
| Aug 10, 2026 | Julie So-Young Kim | CEO | Sale | 89,090 | $17.10 | $1.5M | Form 4 |
| Aug 10, 2026 | Giles Richard Platford | President | Sale | 31,083 | $17.10 | $532K | Form 4 |
| Aug 10, 2026 | Natalie Anne Marie Furney | Global General Counsel | Sale | 30,868 | $17.10 | $528K | Form 4 |
| Aug 10, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Of | Sale | 33,628 | $17.51 | $589K | Form 4 |
| Aug 10, 2026 | Nicola Deidre Petal Greenway | Chief Human Resources Of | Sale | 975 | $17.50 | $17.1K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Andrew Stewart Plump | President, R&D, Director | – | $5.3M | Sep 2, 2026 |
| Teresa Marie Bitetti | President, OBU | – | $1.8M | Nov 2, 2026 |
| Giles Richard Platford | President, IBU | – | $1.7M | Nov 4, 2026 |
| Julie So-Young Kim | President and CEO, Director | – | $1.5M | Aug 10, 2026 |
| Lauren Rusckowski Duprey | Chief Transformation Officer | – | $1.5M | Sep 14, 2026 |
| Nicola Deidre Petal Greenway | Chief Human Resources Officer | – | $957K | Aug 18, 2026 |
| Natalie Anne Marie Furney | Global General Counsel | – | $528K | Aug 10, 2026 |
| Gabriele Ricci | Chief Data & Tech. Officer | – | $429K | Aug 10, 2026 |
| Elaine Mary Shannon | Pres., Global Supply & Quality | – | $425K | Aug 11, 2026 |
| Agosti Marcello Pignagnoli | Head, Strat. & Port. Dev | – | $393K | Aug 10, 2026 |
| Rhonda Janice Pacheco | President, U.S. Business Unit | – | $289K | Aug 10, 2026 |
| Awny Samaan Botros Farajallah | Chief Medical Officer | – | $240K | Aug 10, 2026 |
| Ramy Riad Ahmed Ibrahim | President, PDT BU | – | $124K | Aug 10, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TAK short interest
3.07M TAK shares are sold short. Over the last 12 reports the number of shares short went down 21%.
As of Oct 30, 2026, 3.07M TAK shares were sold short, down 6.8% from the report before. At the average daily volume of 2.99M shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.07M | – | -7% | 2.99M | 1.0 |
| Oct 15, 2026 | 3.29M | – | +13% | 3.00M | 1.1 |
| Sep 30, 2026 | 2.92M | – | -31% | 2.45M | 1.2 |
| Sep 15, 2026 | 4.20M | – | +3% | 2.16M | 1.9 |
| Aug 31, 2026 | 4.09M | – | +37% | 2.22M | 1.8 |
| Aug 14, 2026 | 2.99M | – | +4% | 3.61M | 1.0 |
| Jul 31, 2026 | 2.87M | – | -25% | 4.53M | 1.0 |
| Jul 15, 2026 | 3.82M | – | -27% | 2.97M | 1.3 |
| Jun 30, 2026 | 5.26M | – | -2% | 2.79M | 1.9 |
| Jun 15, 2026 | 5.37M | – | +10% | 3.28M | 1.6 |
| May 29, 2026 | 4.88M | – | +26% | 3.01M | 1.6 |
| May 15, 2026 | 3.88M | – | -22% | 3.49M | 1.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Famous investors that hold TAK
8 of the 50 well-known investors we track reported holding TAK in their latest 13F filing. The largest position is Jim Simons's, worth $41.7M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 2.29M | $41.7M | 0.1% | -11% |
| Israel Englander · Millennium Management | Q3 2026 | 1.33M | $24.2M | 0.0% | +27% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 798,062 | $14.5M | 0.0% | +375% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 438,448 | $8M | 0.0% | +338% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 423,379 | $7.7M | 0.0% | +445% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 86,978 | $1.6M | 0.0% | New |
| Richard Pzena · Pzena Investment Management | Q3 2026 | 45,310 | $824K | 0.0% | +20% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 21,276 | $387K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Takeda Pharmaceutical Co Ltd (TAK) stock
Who owns the most TAK stock?
The largest reported owner of Takeda Pharmaceutical Co Ltd (TAK) is Capital Research Global Investors. In total, 377 funds and institutions reported holding TAK at the end of Q2 2026. See the largest owners.
Are TAK insiders buying or selling?
In the last 12 months, TAK insiders reported no open-market purchases and 22 sales worth $15.2M. The latest trade was on Nov 4, 2026. See every trade.
What is the short interest in TAK?
As of Oct 30, 2026, 3.07M TAK shares were sold short, down 6.8% from the report before. At the average daily volume of 2.99M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold TAK?
8 of the 50 well-known investors we track reported TAK in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $41.7M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.